Pharaoh Neuro has announced that the US Food and Drug Administration has granted Breakthrough Device designation to its ...
As the topic of radiation safety across various interventional specialties continues to garner increased interest, Melissa ...
The UK government has confirmed that it will continue to accept CE marked medical devices on a long-term basis, meaning ...
Resolve Therapeutics has announced two e-posters featuring preclinical data on its RNase-Fc fusion protein RSLV-132, and its ...
The European Society of Minimally Invasive Neurological Therapy (ESMINT) has welcomed five additional national societies to ...
The Shenzhen Institute of Advanced Biomedical Robot (Abrobo)—through close medical-engineering collaboration with Jianmin Liu ...
Von Vascular has announced the publication of a preclinical study evaluating its Algo smart pump with adaptive pulsatile ...
Brainomix and Remedy Pharmaceuticals have announced “promising new findings” from a post-hoc analysis of the Phase 3 CHARM trial. Presented at last week’s World... Late-breaking research presented at ...
Basic and Advanced Neurovascular Anatomy (BANANA) Course 12 January 2026 ...
Ability Neurotech has announced the first-in-human procedure for its brain-computer interface (BCI) technology. Conducted at the Department of Neurosurgery at the Technical University of Munich’s (TUM ...
Phagenesis today announced that the US Food and Drug Administration (FDA) has granted a de novo request for the Phagenyx neurostimulation system, which uses pharyngeal electrical stimulation (PES) to ...
Post-hoc analyses of a large, randomised clinical trial have revealed the potential advantages associated with electronic informed consent (eConsent) in acute ischaemic stroke studies, including ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results